The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.

Author: CiriglianoMarcela, GonzalezPablo, VilaRicardo

Paper Details 
Original Abstract of the Article :
BACKGROUND: Topical combination therapy, such as that with fixed-dose clindamycin/benzoyl peroxide (BPO) or adapalene/BPO, is the recommended first-line approach for the treatment of facial acne. AIMS: To compare the tolerability of clindamycin 1%/BPO 5% gel vs. adapalene 0.1% BPO 2.5% gel for the ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/jocd.12013

データ提供:米国国立医学図書館(NLM)

Topical Acne Treatments: A Head-to-Head Comparison

Acne, a common skin condition, can have a significant impact on an individual's confidence and self-esteem. This study investigates two popular topical treatments for acne, clindamycin/benzoyl peroxide (BPO) and adapalene/BPO, with a focus on their tolerability profiles. The study seeks to provide valuable information for clinicians to choose the most suitable treatment for their patients based on individual tolerability.

The researchers conducted a randomized, single-blind, split-face study on 48 patients with acne. Participants applied clindamycin/BPO and adapalene/BPO to different halves of their faces for two weeks. The study's primary endpoint was investigator-assessed tolerability, specifically focusing on erythema, dryness, and peeling. The results reveal that clindamycin/BPO demonstrated a significantly better tolerability profile than adapalene/BPO.

Tolerability: A Key Factor in Acne Treatment Choice

The study's findings emphasize the importance of considering individual tolerability when choosing topical acne treatments. While both clindamycin/BPO and adapalene/BPO showed comparable efficacy in reducing acne lesions, the researchers found that clindamycin/BPO was significantly better tolerated by patients, particularly in terms of redness, dryness, burning, itching, and scaling. This suggests that clindamycin/BPO may be a preferable choice for patients seeking a treatment with a lower risk of irritation.

Finding the Right Fit for Your Skin: A Personalized Approach

The study's findings underscore the need for personalized acne treatment approaches, considering the unique tolerability profiles of different medications. While both treatments showed efficacy, the study's findings suggest that clindamycin/BPO may be a more comfortable option for many patients, especially those with sensitive skin. Open communication between patients and their healthcare providers is essential to determine the most appropriate treatment strategy based on individual needs and preferences.

Dr. Camel's Conclusion

This research provides valuable insights into the tolerability profiles of two popular topical acne treatments. The findings emphasize the importance of considering individual tolerability in choosing the most suitable treatment for patients. This research contributes to a more personalized approach to acne management, empowering clinicians and patients to make informed decisions that prioritize both effectiveness and patient comfort.

Date :
  1. Date Completed 2013-05-28
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

23174047

DOI: Digital Object Identifier

10.1111/jocd.12013

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.